Economic Recovery and Stimulus Hopes Overshadow Covid Numbers

Optimism surrounding the economic recovery and more stimulus is overshadowing a record daily increase in US covid-19 numbers, the return to lockdown for 5 million Australians and elevated US – Chinese tensions.

Charts (4)

Following on from a fresh all time high for the Nasdaq, Asian markets pushed northwards, and Europe is set to open on the front foot. 

Optimism surrounding the economic recovery and more stimulus is overshadowing a record daily increase in US covid-19 numbers, the return to lockdown for 5 million Australians and elevated US – Chinese tensions. 

Data from China is keeping sentiment buoyed on Thursday. China’s factory gate inflation fell for a fifth straight month in June, as the coronavirus pandemic weighed on the industrial sector. However, signs of recovery are starting to emerge and with the market’s glass half full attitude today, that was enough to underpin sentiment. Chinese PPI -3% in June yoy, slower than the -3.2% decline forecast and an improvement from May’s -3.7%. In the manufacturing sector PPI rose 0.4%, up from -0.4% in May, fuelling hopes that the sector was turning a corner.

Eurogroup to agree on stimulus?
Investors are also hopeful of more government stimulus to support the recovery as the finance minister from the Eurogroup meet today ahead of the summit of leaders next week. 

Optimism is growing that a deal will be agreed over the European recovery Fund. The northern countries are pushing for recovery funds to be loans, the southern European countries and more fiscally challenged nations are pushing for the fund to be in the form of a grant.

Either way, the need for stimulus is becoming apparent. Whilst the region appears to have done a good job containing the virus, the EC has slashed its growth forecasts to -8.7% this year and lower 5.6% growth in the coming year.

US Jobless claims
Looking ahead US jobless claims are under the spotlight for further clues as to how the US labour market is healing. Expectations are for 1.37 million initial jobless claims, down from 1.46 the previous week. 

Continuing claims, which shed light on the rate of re-hiring are expected to be 18.95 million, down from 19.29 million. Whilst this appears to be a frustratingly slow process, taking a step back and looking at the bigger picture offers some perspective. Continuing claims are now down -24% from the peak.

FTSE Chart


More from FTSE 100

Join our live webinars for the latest analysis and trading ideas. Register now

GAIN Capital UK Limited (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.